Halley E. Gilbert - 01 Mar 2022 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Reporting relationship: Chief Legal Officer
Issuer ticker: NEO
Reported as of: 01 Mar 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Mar 2022, 18:59:44 UTC
Prior SEC filing: 08 Feb 2022
Next SEC filing: 03 Jun 2022
Source filing: View source filing
Reporting owner signature: /s/ Halley E. Gilbert

Key filing fact

Halley E. Gilbert filed Form 4 for NEOGENOMICS INC (NEO) on 03 Mar 2022.

Key facts

This page summarizes Halley E. Gilbert's Form 4 filing for NEOGENOMICS INC (NEO).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 03 Mar 2022, 18:59.

Change

Previous filing in this sequence was filed on 08 Feb 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NEO transaction

Common Stock

Award

Transaction value: $0
Shares: +42,036
Change %: +40%
Price: $0.000000
Shares after: 147,396
Date: 01 Mar 2022
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NEO transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +102,623
Change %
Price: $0.000000
Shares after: 102,623
Date: 01 Mar 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 102,623
Exercise price: $21.41
Footnotes: F4

NEO holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 63,331
Date: 01 Mar 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 63,331
Exercise price: $42.21
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

On March 1, 2022, Ms. Gilbert was granted 42,036 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date.

Footnote F2

This balance includes 97 shares that were acquired at a price of $19.16 per share pursuant to NeoGenomics's Employee Stock Purchase Plan (ESPP) during the month ended January 31, 2022. The shares were acquired in transactions exempt from Section 16b-3.

Footnote F3

On August 17, 2021, Ms. Gilbert was granted 63,331 stock options. These options vest ratably over the first four anniversary dates of the grant date.

Footnote F4

On March 1, 2022, Ms. Gilbert was granted 102,623 stock options. These options vest ratably over the first four anniversary dates of the grant date.